NASDAQ:AMLX | Profit Breakdown | Amylyx Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$45.69M-$43.42M
2026-03-31-$43.78M-$41.28M
2025-12-31$0.00-$36.61M-$32.95M-$33M
2025-09-30$0.00-$36.03M-$34.39M-$34.39M
2025-06-30$0.00-$42.86M-$41.44M-$41.44M
2025-03-31$0.00-$37.8M-$35.91M-$35.91M
2024-12-31-$665,000.00-$40.65M-$38.18M-$37.55M
2024-09-30$416,000.00-$75.66M-$72.7M-$72.7M
2024-06-30-$1.02M-$76.29M-$72.7M-$72.7M
2024-03-31$88.64M-$122.13M-$118.55M-$118.79M
2023-12-31$108.45M$1.93M$6.48M$4.73M
2023-09-30$102.69M$18.72M$22.41M$20.89M
2023-06-30$98.22M$20.2M$24.01M$22.07M
2023-03-31$71.43M-$2.05M$1.4M$1.57M
2022-12-31$21.89M-$44.59M-$42.13M-$42.7M
2022-09-30$345,000.00-$54.68M-$53.88M-$53.76M
2022-06-30-$54.25M-$53.89M-$54.07M
2022-03-31-$47.81M-$47.7M-$47.85M
2021-12-31$0.00-$28.32M-$28.34M-$28.34M
2021-09-30$285,000.00-$22.92M-$23.14M-$23.14M
2021-06-30-$18.59M-$21.92M-$21.92M
2021-03-31-$12.87M-$14.52M-$14.52M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$153.29M-$144.69M-$144.74M
2024-12-31$87.37M-$314.73M-$302.14M-$301.74M
2023-12-31$380.79M$38.8M$54.3M$49.27M
2022-12-31$22.23M-$201.34M-$197.6M-$198.38M
2021-12-31$285,000.00-$82.69M-$87.93M-$87.93M